PHARMA CONGRESS SPRING 2003: HHS OIG COMPLIANCE GUIDANCE FOR THE PHARMACEUTICAL INDUSTRY: KEY INSIGHTS FROM REGULATORS AND COMPLIANCE EXPERTS
Omni Shoreham Hotel
Washington, DC
June 8-9, 2003
|
Sponsored by
|
|
|
Supported by
|
|
For future information about The Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum, please complete the form below.
|
|
STREAMING VIDEO OF PRESENTATION BY OIG CHIEF COUNSEL LEW MORRIS
|
As Seen on Pharma Congress CD-ROM Described below.
Click here to view now!
|
|
NOW AVAILABLE!
|
Purchase a CD-ROM which includes video of all speakers plus synced powerpoint presentations.
PharmaCongress Spring 2003:
HHS OIG Compliance Guidance for the Pharmaceutical Industry: Key Insights from Regulators and Compliance Experts
The video, synchronized with the speaker presentations, can easily be viewed using your computer. You can instantly navigate to the presenter and the exact content you wish to view.
Ensure your team's knowledge is current.
Click here for more details
and to order your copy today!
|
|
Keynote Speakers:
Lewis Morris, Esq.
Chief Counsel to the Inspector General
Office of Inspector General
Department of Health and Human Services
Washington, DC
Charles Tetzlaff, Esq.
General Counsel, U.S. Sentencing Commission
Washington DC
Susan Winkler, Esq.
Assistant U.S. Attorney and Deputy Health Care Fraud Chief
Boston, MA
Jeffrey B. Kindler, Esq.
Senior Vice President and General Counsel
Pfizer Inc.
New York, NY
Featured Faculty:
John Bentivoglio, Esq.
Partner, Arnold and Porter
Former Special Counsel for Healthcare Fraud and Chief Privacy Officer
United States Department of Justice
Washington, DC
Patrick Davish
Executive Director, Public Affairs & Policy
Merck & Co, Inc.
North Wales, PA
Hugh M. Donnelly
Vice President, Audit
Pfizer Inc,
New York, NY
Janice Forsyth
Vice President & Chief Compliance Officer
Express Scripts, Inc.
St. Louis, MO
Stuart Fullerton
Senior Litigation Counsel, AstraZeneca
Pharmaceuticals, LLP
Wilmington, DE
Jeff Greenman
Chief Compliance Officer
Bayer Pharmaceuticals Corporation
West Haven, CT
Robert G. Homchick, Esq.
Partner, Davis Wright Tremaine
Seattle, WA
Paul Kalb, MD, JD
Partner, Sidley Austin Brown & Wood
Washington, DC
Bradford W. Kling
Alcon Laboratories, Inc.
Vice President, Corporate Audit
Fort Worth, TX
Douglas Lankler, Esq.
Senior Corporate Counsel
Deputy Corporate Compliance Officer
Pfizer Inc.
New York, NY
Beth Levine, Esq.
General Counsel, U.S. Pharmaceuticals
Pfizer Inc.
New York, NY
Ann E. Lewis
Senior Corporate Counsel
Pfizer Inc.
New York, NY
Karen R. Lines, Esq.
Associate General Counsel, Genentech Inc.
San Francisco, CA
Lori Queisser, CPA
Vice President and Chief Compliance Officer
Eli Lilly and Company
Indianapolis, IN
Arjun Rajaratnam, Esq.
Compliance Officer, Global Pharmaceuticals
GlaxoSmithKline
Research Triangle Park, NC
Mary E. Riordan, Esq.
Senior Counsel
Office of Counsel to the Inspector General
Office of Inspector General
Department of Health and Human Services
Washington, DC
Brenton Saunders, JD, MBA
Partner, PricewaterhouseCoopers
Past President, Health Care Compliance Association
Founder and Chair-elect, International Association of Privacy Officers,
Washington, DC
Jeff Stewart
Vice President, Compliance
Ortho Biotech, a Johnson & Johnson Company
Raritan, NJ
Janice Toran
Vice President, Compliance
Fujisawa Healthcare, Inc.
Deerfield, IL
Bert Weinstein
Vice President and Assistant General Counsel
Merck & Co.
Whitehouse Station, NJ
|
|
